UK Department of Health & Social Care

04/09/2026 | Press release | Distributed by Public on 04/09/2026 04:13

RSV immunisation programme: JCVI advice, 18 March 2026

Independent report

RSV immunisation programme: JCVI advice, 18 March 2026

Statement setting out the findings from JCVI's initial considerations on respiratory syncytial virus (RSV) vaccination in those with underlying health conditions and advice on clinical risk groups for RSV.

From: Department of Health and Social Care Published 9 April 2026
Get emails about this page

Documents

Details

This statement sets out advice from JCVI on extending the RSV immunisation programme to include adults aged 65 to 74 years with the following underlying health conditions:

  • chronic respiratory disease
  • immunosuppression due to disease or treatment

Updates to this page

Published 9 April 2026

Sign up for emails or print this page

Get emails about this page
Print this page

Explore the topic

UK Department of Health & Social Care published this content on April 09, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 09, 2026 at 10:13 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]